{"id":"https://openalex.org/W30717985","doi":null,"title":"Drugs in development for Parkinson's disease.","display_name":"Drugs in development for Parkinson's disease.","publication_year":2004,"publication_date":"2004-07-01","ids":{"openalex":"https://openalex.org/W30717985","mag":"30717985","pmid":"https://pubmed.ncbi.nlm.nih.gov/15298067"},"language":"en","primary_location":{"id":"pmid:15298067","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15298067","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W30717985"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Tom H Johnston","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2799337515","display_name":"Toronto Western Hospital","ror":"https://ror.org/03qv8yq19","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2799337515"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Tom H Johnston","raw_affiliation_strings":["Toronto Western Research Institute, Toronto Western Hospital, University Health Network, 399 Bathurst Street, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Toronto Western Research Institute, Toronto Western Hospital, University Health Network, 399 Bathurst Street, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2799337515"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018228116","display_name":"Jonathan M. Brotchie","orcid":"https://orcid.org/0000-0003-2337-0816","observed_orcids":["https://orcid.org/0000-0003-2337-0816"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan M Brotchie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.7199,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.96055319,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"5","issue":"7","first_page":"720","last_page":"726"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.9089999794960022},{"id":"https://openalex.org/keywords/rasagiline","display_name":"rasagiline","score":0.8999999761581421},{"id":"https://openalex.org/keywords/mao-b-inhibitors","display_name":"monoamine oxidase B inhibitors","score":0.7559999823570251},{"id":"https://openalex.org/keywords/catechol-o-methyltransferase-inhibitors","display_name":"catechol-O-methyltransferase inhibitors","score":0.9729999899864197},{"id":"https://openalex.org/keywords/monoamine-reuptake-inhibitors","display_name":"monoamine reuptake inhibitors","score":0.7789999842643738},{"id":"https://openalex.org/keywords/dopamine-agonists","display_name":"dopamine agonists","score":0.9679999947547913},{"id":"https://openalex.org/keywords/rotigotine","display_name":"rotigotine","score":0.921999990940094},{"id":"https://openalex.org/keywords/levodopa-induced-dyskinesia","display_name":"levodopa-induced dyskinesia","score":0.9049999713897705},{"id":"https://openalex.org/keywords/alpha2-adrenoceptor-antagonists","display_name":"alpha2-adrenoceptor antagonists","score":0.8799999952316284},{"id":"https://openalex.org/keywords/adenosine-a2a-receptor-antagonist","display_name":"adenosine A2A receptor antagonists","score":0.9079999923706055},{"id":"https://openalex.org/keywords/ampa-receptor-antagonists","display_name":"AMPA receptor antagonists","score":0.9070000052452087},{"id":"https://openalex.org/keywords/levetiracetam","display_name":"levetiracetam","score":0.8840000033378601},{"id":"https://openalex.org/keywords/5-ht1a-receptor-agonist","display_name":"5-HT1A receptor agonist","score":0.8169999718666077},{"id":"https://openalex.org/keywords/5-ht2a-antagonist","display_name":"5-HT2A antagonist","score":0.9340000152587891},{"id":"https://openalex.org/keywords/neuroprotective-agents","display_name":"neuroprotective agents","score":0.902999997138977},{"id":"https://openalex.org/keywords/growth-factors","display_name":"growth factors","score":0.7089999914169312},{"id":"https://openalex.org/keywords/serotonergic-system","display_name":"serotonergic system","score":0.4959999918937683}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6683982610702515},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.531109631061554},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.4671677350997925},{"id":"https://openalex.org/C2781249495","wikidata":"https://www.wikidata.org/wiki/Q420685","display_name":"Rasagiline","level":4,"score":0.46600183844566345},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.4386121332645416},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.42390793561935425},{"id":"https://openalex.org/C2779908668","wikidata":"https://www.wikidata.org/wiki/Q834280","display_name":"Bupropion","level":3,"score":0.4127788543701172},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.2665024697780609},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25042107701301575},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.12584221363067627},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":true},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15298067","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15298067","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},{"id":"mag:30717985","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15298067","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W2003372361","https://openalex.org/W2053958304","https://openalex.org/W2464913307","https://openalex.org/W2437654046","https://openalex.org/W2260292956","https://openalex.org/W2142943671","https://openalex.org/W1980233570","https://openalex.org/W2151130663","https://openalex.org/W6697559854","https://openalex.org/W2045915839","https://openalex.org/W2029551321","https://openalex.org/W1431002902","https://openalex.org/W2267699479","https://openalex.org/W2011169499","https://openalex.org/W6707182478","https://openalex.org/W1998093552","https://openalex.org/W1997830697","https://openalex.org/W2026206241","https://openalex.org/W2019287715","https://openalex.org/W2912159837","https://openalex.org/W2068544831","https://openalex.org/W2107051416","https://openalex.org/W2170366267","https://openalex.org/W2116836111","https://openalex.org/W2620548407","https://openalex.org/W2524648746","https://openalex.org/W2027113770","https://openalex.org/W2144354711","https://openalex.org/W2154452421","https://openalex.org/W1968449137","https://openalex.org/W2010387852","https://openalex.org/W2411092742","https://openalex.org/W2079022015","https://openalex.org/W1972277684","https://openalex.org/W2110185529","https://openalex.org/W2283801189"],"related_works":["https://openalex.org/W2416327217","https://openalex.org/W2124532066","https://openalex.org/W2386495541","https://openalex.org/W1515564442","https://openalex.org/W2026052382","https://openalex.org/W2076873460","https://openalex.org/W2355024549","https://openalex.org/W35778960","https://openalex.org/W7161758342","https://openalex.org/W3026187987"],"abstract_inverted_index":{"Pharmacological":[0],"treatment":[1,113],"of":[2,21,25,36,45,51,75,114,168,188],"Parkinson's":[3],"disease":[4,178],"(PD)":[5],"is":[6],"entering":[7],"a":[8,22,73,165],"new":[9,88],"and":[10,34,42,48,64,77,84,86,116,143,157,208],"exciting":[11],"era.":[12],"Real":[13],"promise":[14],"now":[15],"exists":[16],"for":[17,90],"the":[18,37,65,112],"clinical":[19],"application":[20],"large":[23],"range":[24,74],"molecules":[26],"in":[27,111],"development":[28],"that":[29,105,145,171],"will":[30,106],"combat":[31],"different":[32],"aspects":[33],"stages":[35],"condition.":[38],"These":[39,119,180],"include":[40,120,181],"methyl-":[41],"ethyl-esterified":[43],"forms":[44],"L-dopa":[46],"(etilevodopa":[47],"melevodopa),":[49],"inhibitors":[50,184,205],"enzymes":[52],"such":[53,150],"as":[54,151],"monoamine":[55,66],"oxidase":[56],"type-B":[57],"(eg,":[58,62,69,81,95,125,131,136,141,155,160,185,191,195,198,201,206],"rasagiline),":[59],"catechol-O-methyl":[60],"transferase":[61],"BIA-3202)":[63],"re-uptake":[67],"mechanism":[68],"brasofensine).":[70],"In":[71],"addition,":[72],"full":[76],"partial":[78],"dopamine":[79],"agonists":[80,154],"sumanirole,":[82],"piribedil":[83],"BP-897)":[85],"their":[87],"formulations,":[89],"example,":[91],"patch":[92],"delivery":[93],"systems":[94,149],"rotigotine)":[96],"are":[97],"being":[98],"developed.":[99],"We":[100],"also":[101],"highlight":[102],"non-dopaminergic":[103],"treatments":[104],"have":[107],"wide":[108],"ranging":[109],"applications":[110],"PD":[115],"L-dopa-induced":[117],"dyskinesia.":[118],"alpha2":[121],"adrenergic":[122],"receptor":[123,129,134],"antagonists":[124,130,135,159],"fipamezole),":[126],"adenosine":[127],"A2A":[128],"istradefylline),":[132],"AMPA":[133],"talampanel),":[137],"neuronal":[138],"synchronization":[139],"modulators":[140,187],"levetiracetam)":[142],"agents":[144,170],"interact":[146],"with":[147],"serotonergic":[148],"5-hydroxytryptamine":[152],"(5-HT)1A":[153],"sarizotan)":[156],"5-HT2A":[158],"quetiapine).":[161],"Lastly,":[162],"we":[163],"examine":[164],"growing":[166],"number":[167],"neuroprotective":[169],"seek":[172],"to":[173],"halt":[174],"or":[175],"even":[176],"reverse":[177],"progression.":[179],"anti-apoptotic":[182],"kinase":[183],"CEP-1347),":[186],"mitochondrial":[189],"function":[190],"creatine),":[192],"growth":[193],"factors":[194],"leteprinim),":[196],"neuroimmunophilins":[197],"V-10367),":[199],"estrogens":[200],"MITO-4509),":[202],"c-synuclein":[203],"oligomerization":[204],"PAN-408)":[207],"sonic":[209],"hedgehog":[210],"ligands.":[211]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
